Altimmune (ALT) Non-Current Deferred Tax Liability: 2017-2019
Historic Non-Current Deferred Tax Liability for Altimmune (ALT) over the last 2 years, with Jun 2019 value amounting to $58,500.
- Altimmune's Non-Current Deferred Tax Liability fell 98.68% to $58,500 in Q2 2019 from the same period last year, while for Jun 2019 it was $58,500, marking a year-over-year decrease of 98.68%. This contributed to the annual value of $58,500 for FY2018, which is 99.01% down from last year.
- Latest data reveals that Altimmune reported Non-Current Deferred Tax Liability of $58,500 as of Q2 2019, which was down 0.00% from $58,500 recorded in Q1 2019.
- In the past 5 years, Altimmune's Non-Current Deferred Tax Liability ranged from a high of $8.5 million in Q2 2017 and a low of $58,500 during Q4 2018.
- Over the past 3 years, Altimmune's median Non-Current Deferred Tax Liability value was $4.4 million (recorded in 2018), while the average stood at $4.0 million.
- Data for Altimmune's Non-Current Deferred Tax Liability shows a maximum YoY plummeted of 99.01% (in 2018) over the last 5 years.
- Quarterly analysis of 3 years shows Altimmune's Non-Current Deferred Tax Liability stood at $5.9 million in 2017, then plummeted by 99.01% to $58,500 in 2018, then slumped by 98.68% to $58,500 in 2019.
- Its Non-Current Deferred Tax Liability was $58,500 in Q2 2019, compared to $58,500 in Q1 2019 and $58,500 in Q4 2018.